According to Harvard Bioscience's latest financial reports the company's current revenue (TTM ) is โฌ75.04 Million. In 2024 the company made a revenue of โฌ90.46 Million a decrease over the revenue in the year 2023 that were of โฌ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.